Company Performance Metrics
Hans Pedersen: CEO, Co-Founder & Co-Owner
Thomas Vitzthum: CFO, Co-Founder & Co-Owner
Flowsion is a medical device company focused on the design, development and commercialization of a product platform specifically for the in-hospital continuous glucose monitoring market. Their initial focus is on the development of an intravenous sensor specifically for tight glycemic control (TGC) in the critical care market.
The Diramo system
is intended to continuously measure, record and track the blood glucose level (BGL) in critically ill patients (i.e., those patients under intensive-care treatment within an ICU).
The Diramo system is intended to measure blood glucose in venous blood as well as provide information to health-care professionals on current glucose levels and to provide appropriate alarms and trends in case of hypo- and hyperglycaemic readings by the device.
Protection of their intellectual property is a strategic priority for their business. They rely on a combination of patent, copyright and other intellectual property laws, trade secrets, nondisclosure agreements and other measures to protect their proprietary rights.
